Licensing agreements with Canadian sleep experts Dr. Magdy Younes for sleep diagnostic software and hardware and Dr. Norah Vincent for the RestEd Treatment program are part of the movement to change the future of sleep analysis and treatment.
For Immediate Release
Cerebra, a sleep-focused digital health company, is pleased to announce the completion of two new licensing agreements. The first is with Dr. Magdy Younes of Younes Respiratory Technologies Inc. for sleep diagnostic software including a series of proprietary, advanced digital sleep analysis metrics, that are used by leading researchers around the world and are available in western Canada through Cerebra’s sleep analysis service. The second expands Cerebra’s Canadian distribution partnership agreement with Dr. Norah Vincent to bring her cognitive behavioral therapy (CBT) product for insomnia, RestEd, to Manitoba.
The renewed and revised Younes licensing agreement secures Cerebra rights to a collection of proprietary sleep metrics and digital biomarkers that is viewed by many as the world’s best system for digital sleep analysis. These metrics include the proprietary Odds Ratio Product (ORP Sleep Depth), an objective, fully-digital, continuous measurement of sleep depth which is helping experts gain a deeper understanding of sleep, sleep disorders and treatment options. The license grants exclusive use of these metrics for home sleep testing services including use with the Cerebra sleep testing hardware, in-lab and in-home clinical sleep diagnosis and its application in consumer sleep devices for personal sleep monitoring.
ORP Sleep Depth has been validated in dozens of studies and is changing the way we look at sleep. By analyzing brain activity while we sleep, it can be applied to help understand the impact and severity of common sleep disorders, including sleep apnea and insomnia. ORP Sleep Depth expresses how likely you are to wake at any moment and is uniquely able to detect the effect of subtle changes in your environment as well as describe your natural ability to return to sleep after a momentary disturbance.
RestEd, a recognized and proven online CBT program for insomnia, was developed by Dr. Norah Vincent, a clinical psychologist who treats sleep difficulties and has been performing research in the sleep treatment field for many years. The Canadian Sleep Society reports about 10% of the adult population in Canada experience persistent insomnia and an additional 20-25% reports occasional insomnia symptoms. RestEd makes treatment easily available to those struggling with poor sleep and is now available from Cerebra in all of Canada, outside of Quebec.
“These licensing agreements reinforce Cerebra’s global leadership position in digital sleep analysis,” says Cerebra CEO Dawson Reimer. “This in conjunction with treatment tools such as RestEd, provides a unique opportunity to help people achieve their best possible sleep.”
The Younes license agreement includes rights to Cerebra digital sleep analysis software and Michele, an FDA/EU-CE marked/Health Canada approved sleep diagnostic software that is one of the most validated systems for auto-sleep staging. The Michele software is well-established for clinical use in sleep diagnosis and EEG analysis, and researchers are also investigating use of the underlying digital sleep metrics in a variety of other clinical conditions such as dementia, psychiatric disorders and in-hospital patient monitoring, as well as in supporting future systems for personal sleep analysis and optimization.
For more information or to schedule an interview contact:
Mary Fearon or Lindsay Glasspoole
email@example.com / firstname.lastname@example.org
About Odds Ratio Product (ORP)
The development of ORP Sleep Depth as a digital measure of sleep quality is a breakthrough in sleep analysis technology and continues to fuel new research, helping to advance our understanding of brain activity when we sleep and its impact on quality of life, performance and longevity. ORP is based on power spectral analysis of the EEG signal and was developed by renowned medical researcher Dr. Magdy Younes in response to the limitations offered by the conventional “R&K” method for staging sleep.
ORP Sleep Depth is available exclusively through the Cerebra Research Portal, Prodigy DSA and Michele Sleep Scoring. Prodigy DSA is medical device software that has received approval by Health Canada for use in the assessment of sleep and diagnosis of sleep disorders. Michele Sleep Scoring is medical device software that has received approval in Canada, the European Union and the United States of America.
Cerebra Health Inc. is a Canadian digital health company focused on improving access to advanced digital sleep analysis and diagnostic technology for the assessment of sleep and the diagnosis of sleep disorders.
Cerebra Medical, a wholly owned subsidiary of Cerebra Health, operates an ISO 13485:2016 certified Quality Management System for the design, development and manufacture of EEG sleep monitoring systems and medical device software for collection and analysis of physiological data recorded during sleep. Cerebra Medical holds an MDSAP certificate in conformance with the requirements of Health Canada and FDA.
Cerebra’s sleep study services provide unmatched capabilities for in-home sleep analysis, with a focus on improved user experience, state-of-the-art technology, and increased operational efficiency. Cerebra is also working in partnership with leading sleep scientists and researchers to revolutionize clinical sleep medicine by leveraging its core capabilities in digital sleep analysis.